Evidence map›Paper›PMID 38170524›Full record

ArticleJAMA network open2024

Physiology- or Imaging-Guided Strategies for Intermediate Coronary Stenosis.

Seokhun Yang, Jeehoon Kang, Doyeon Hwang, Jinlong Zhang, Jun Jiang, Xinyang Hu, Joo-Yong Hahn, Chang-Wook Nam, Joon-Hyung Doh, Bong-Ki Lee and 19 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 18 institutions in 2 countries.

Seokhun YangSeoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
Jeehoon KangSeoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
Doyeon HwangSeoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
Jinlong ZhangThe Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
Jun JiangThe Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
Xinyang HuThe Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
Joo-Yong HahnSamsung Medical Center, Seoul, Republic of Korea.
Chang-Wook NamKeimyung University Dongsan Medical Center, Daegu, Republic of Korea.
Joon-Hyung DohInje University Ilsan Paik Hospital, Goyang, Republic of Korea.
Bong-Ki LeeKangwon National University Hospital, Chuncheon, Gangwon-Do, Republic of Korea.
Weon KimKyung Hee University Hospital, Seoul, Republic of Korea.
Jinyu HuangAffiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Fan JiangHangzhou Normal University Affiliated Hospital, Hangzhou, China.
Hao ZhouThe 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Peng ChenThe 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Lijiang TangZhejiang Hospital, Hangzhou, China.
Wenbing JiangThe Third Clinical Institute Affiliated To Wenzhou Medical University, Wenzhou, China.
Xiaomin ChenNingbo First Hospital, Ningbo, China.
Wenming HeThe Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
Sung Gyun AhnWonju Severance Christian Hospital, Wonju, Gangwon-Do, Republic of Korea.
Myeong-Ho YoonAjou University Hospital, Suwon, Republic of Korea.
Ung KimYeungnam University Medical Center, Daegu, Republic of Korea.
Joo Myung LeeSamsung Medical Center, Seoul, Republic of Korea.
You-Jeong KiUijeongbu Eulji Medical Center, Uijeongbu, Gyeonggi-Do, Republic of Korea.
Eun-Seok ShinUlsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
Hyo-Soo KimSeoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
Seung-Jea TahkAjou University Hospital, Suwon, Republic of Korea.
Jian'an WangThe Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
Bon-Kwon KooSeoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
Seoul National University Hospital · KRSecond Affiliated Hospital of Zhejiang University · CNWenzhou Medical University · CNAjou University Hospital · KRSamsung Medical Center · KRAffiliated Hospital of Hangzhou Normal University · CNHangzhou First People's Hospital · CNInje University Ilsan Paik Hospital · KRKangwon National University Hospital · KRKeimyung University · KRKyung Hee University Dental Hospital · KRNingbo First Hospital · CNNingbo University Affiliated Hospital · CNThe Catholic University of Korea Uijeongbu St. Mary's Hospital · KRUniversity of Ulsan · KRWonju Severance Christian Hospital · KRYeungnam University Medical Center · KRZhejiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Treatment strategies for intermediate coronary lesions guided by fractional flow reserve (FFR) and intravascular ultrasonography (IVUS) have shown comparable outcomes. Identifying low-risk deferred vessels to ensure the safe deferral of percutaneous coronary intervention (PCI) and high-risk revascularized vessels that necessitate thorough follow-up can help determine optimal treatment strategies. Objectives: To investigate outcomes according to treatment types and FFR and IVUS parameters after FFR- or IVUS-guided treatment. Design, Setting, and Participants: This cohort study included patients with intermediate coronary stenosis from the Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in Patients With Intermediate Stenosis (FLAVOUR) trial, an investigator-initiated, prospective, open-label, multicenter randomized clinical trial that assigned patients into an IVUS-guided strategy (which recommended PCI for minimum lumen area [MLA] ≤3 mm2 or 3 mm2 to 4 mm2 with plaque burden [PB] ≥70%) or an FFR-guided strategy (which recommended PCI for FFR ≤0.80). Data were analyzed from November to December 2022. Exposures: FFR or IVUS parameters within the deferred and revascularized vessels. Main Outcomes and Measures: The primary outcome was target vessel failure (TVF), a composite of cardiac death, target vessel myocardial infarction, and revascularization at 2 years. Results: A total of 1619 patients (mean [SD] age, 65.1 [9.6] years; 1137 [70.2%] male) with 1753 vessels were included in analysis. In 950 vessels for which revascularization was deferred, incidence of TVF was comparable between IVUS and FFR groups (3.8% vs 4.1%; P = .72). Vessels with FFR greater than 0.92 in the FFR group and MLA greater than 4.5 mm2 or PB of 58% or less in the IVUS group were identified as low-risk deferred vessels, with a decreased risk of TVF (hazard ratio [HR], 0.25 [95% CI, 0.09-0.71]; P = .009). In 803 revascularized vessels, the incidence of TVF was comparable between IVUS and FFR groups (3.6% vs 3.7%; P = .95), which was similar in the revascularized vessels undergoing PCI optimization (4.2% vs 2.5%; P = .31). Vessels with post-PCI FFR of 0.80 or less in the FFR group or minimum stent area of 6.0 mm2 or less or with PB at stent edge greater than 58% in the IVUS group had an increased risk for TVF (HR, 7.20 [95% CI, 3.20-16.21]; P < .001). Conclusions and Relevance: In this cohort study of patients with intermediate coronary stenosis, FFR- and IVUS-guided strategies showed comparable outcomes in both deferred and revascularized vessels. Binary FFR and IVUS parameters could further define low-risk deferred vessels and high-risk revascularized vessels.

Indexed as

Coronary StenosisFractional Flow Reserve, MyocardialPercutaneous Coronary InterventionPlaque, AtheroscleroticAgedCohort StudiesCoronary AngiographyFemaleHumansMaleMiddle AgedMulticenter Studies as TopicProspective StudiesRandomized Controlled Trials as Topic

Identifiers

PMID38170524
PMCPMC10765263
OpenAlexW4390546580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.